Nevro (NYSE: NVRO) is a public multinational medical technology company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has impacted the lives of over 28,000 patients around the world.
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
The Senior Manager, Investor Relations & Corporate Strategy will have a key role in the Company’s investor relations strategy and will provide insight to management and cross-functional teams to guide corporate decision-making through quantitative and qualitative analyses.
The Senior Manager, Investor Relations & Corporate Strategy will have significant interaction with the executive, commercial, clinical, R&D and finance teams, as well as the field-based sales force, and must demonstrate clear ability to communicate and work effectively in a team environment.